Transforming manufacturing and packaging at PHARMAP 2025
The pharmaceutical industry is increasingly prioritising sustainability, with many companies taking steps toward reducing their environmental impact. The European pharmaceutical…
Partner Content
-
-
How CNS researchers are handling clinical trial turbulence
The field of central nervous system (CNS) drug development is awash with activity. Data from GlobalData’s drugs database, as of…
-
Navigating the complexities of sustainable specialty pharma supply chains
The pharmaceutical world is changing. Sales of personalised therapies, for example, will skyrocket from $8 billion in 2022 to a…
-
Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?
The pharmaceutical industry is facing growing complexity in clinical trials, contributing to longer timelines and ultimately higher costs. These complexities…
-
Oncology and eClinical solutions: How one company is adapting to the challenges
Meticulous planning is central to building an effective clinical trial, powered by well-designed Interactive Response Technology (IRT) which provides not…
-
Revolutionary approaches to drug design: how AI is transforming life sciences
With 2025 well underway, the runaway momentum of artificial intelligence (AI) looks unstoppable. GlobalData estimates that the total AI market…
-
43rd Annual JP Morgan Healthcare Conference 2025
The 43rd Annual JP Morgan Healthcare Conference took place in San Francisco, California on January 13–16, 2025. This annual conference…
-
The spoken revolution in rater training assessment
In a significant move that could reshape how pharmaceutical companies conduct CNS clinical trials, Cambridge Cognition has unveiled in-house rater…
-
How AI is streamlining cell and gene therapy manufacturing
AI has frequently been in the headlines recently due to its potentially transformative capabilities — and the technology is making…
-
Immunotherapeutic responses and their assessments
Immunotherapeutics have transformed the landscape of cancer outcomes. It is crucial that the atypical response patterns seen with them are…